About KPL
KPL is a Healthcare company based in Gaithersburg (United States) founded in 1979, and was acquired by SeraCare in August 2013. Manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics. KPL offers products and services including NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
As of Aug 19, 2013 KPL operates as a subsidiary of Seracare Life Sciences. KPL develops, manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics. KPL was claims to be the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. Since then KPL has introduced over 800 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry, and molecular biology scientists. SeraCares portfolio of KPL products includes primary and secondary antibodies as well as reagents and kits targeting ELISA, western blotting, immunohistology, protein labeling, nucleic acid labeling, sample preparation, protein purification, and recombinant protein detection and analysis.
Products & Services of KPL
KPL offers a comprehensive portfolio of products and services, including NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents.
Reference standards for next-generation sequencing in diagnostics.
Materials for validating and monitoring assay performance.
Reagents to support research and IVD assay development.
Investors in KPL
KPL has secured backing from 1 investor. Prominent investors backing the company include SeraCare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability | 1984 | seracare.com | Milford, United States |
Investor details for KPL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of KPL
2 dated milestones of KPL across 34 years, from founding to its latest funding, stage changes and deals.
- Founded KPL is founded.
- Exit Acquired by SeraCare.
Competitors of KPL
KPL has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of KPL
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of KPL
Websites that share an audience with KPL (kpl.com).
Websites whose visitors overlap most with KPL. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jacksonimmuno.com | 100% | #680,486 | View details | ||
| ebioscience.com | 96% | View details | |||
| randox-lifesciences.com | 94% | View details | |||
| southernbiotech.com | 89% | #1,646,016 | View details | ||
| invitrogen.com | 88% | 5.2K | #3,688,642 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 30 similar websites and full traffic analytics for KPL
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as KPL (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about KPL
KPL was founded in 1979.
KPL is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
As of Aug 19, 2013 KPL operates as a subsidiary of Seracare Life Sciences. KPL develops, manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics. KPL was claims to be the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. Since then KPL has introduced over 800 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry, and molecular biology scientists. SeraCares portfolio of KPL products includes primary and secondary antibodies as well as reagents and kits targeting ELISA, western blotting, immunohistology, protein labeling, nucleic acid labeling, sample preparation, protein purification, and recombinant protein detection and analysis.
KPL's top competitors include GenScript, Epitomics and Vector Laboratories.
KPL offers NGS Solutions, Controls & Reference Materials, and Immunoassay Reagents.
KPL has 1 investor. Key investors include SeraCare.
Yes. KPL was acquired by SeraCare in August 2013.